The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization
Open accessAbstract
Background: Tumor-associated macrophages (TAM) play an important role in tumor microenvironment. Particularly, M2 macrophages contribute to tumor progression, depending on the expression of NF-κB. Tumor-derived exosomes can modulate tumor microenvironment by transferring miRNAs to immune cells. Epigallocatechin gallate (EGCG) has well known anti-tumor effects; however, no data are available on the influence of EGCG on communication with cancer cells and TAM. Methods: Murine breast cancer cell lines, 4T1, was used for in vivo and ex vivo studies. Exosome was extracted from EGCG-treated 4T1 cells, and the change of miRNAs was screened using microarray. Tumor cells or TAM isolated from murine tumor graft were incubated with exosomes derived from EGCG-treated and/or miR-16 inhibitor-transfected 4T1 cells. Chemokines for monocytes (CSF-1 and CCL-2), cytokines both with high (IL-6 and TGF-β) and low (TNF-α) expression in M2 macrophages, and molecules in NF-κB pathway (IKKα and Iκ-B) were evaluated by RT-qPCR or western blot. Results: EGCG suppressed tumor growth in murine breast cancer model, which was associated with decreased TAM and M2 macrophage infiltration. Expression of chemokine for monocytes (CSF-1 and CCL-2) were low in tumor cells from EGCG-treated mice, and cytokines of TAM was skewed from M2- into M1-like phenotype by EGCG as evidenced by decreased IL-6 and TGF-β and increased TNF-α. Ex vivo incubation of isolated tumor cells with EGCG inhibited the CSF-1 and CCL-2 expression. Ex vivo incubation of TAM with exosomes from EGCG-treated 4T1 cells led to IKKα suppression and concomitant I-κB accumulation; increase of IL-6 and TGF-β; and, decrease of TNF-α. EGCG up-regulated miR-16 in 4T1 cells and in the exosomes. Treatment of tumor cells or TAM with exosomes derived from EGCG-treated and miR-16-knock-downed 4T1 cells restored the above effects on chemokines, cytokines, and NF-κB pathway elicited by EGCG-treated exosomes. Conclusions: Our data demonstrate that EGCG up-regulates miR-16 in tumor cells, which can be transferred to TAM via exosomes and inhibits TAM infiltration and M2 polarization. We suggest a novel mechanism by which EGCG exerts anti-tumor activity via regulation of TAM in tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Self-citationSkog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Nanotubular Highways for Intercellular Organelle Transport
Rustom, A., Saffrich, R., Markovic, I., Walther, P., & Gerdes, H.-H. (2004) · Science · doi:10.1126/science.1093133 · Cited by 2,038
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Heijnen, H. F. G., Schiel, A. E., Fijnheer, R., Geuze, H. J., & Sixma, J. J. (1999) · Blood · doi:10.1182/blood.v94.11.3791 · Cited by 1,487
Role of Rab GTPases in Membrane Traffic and Cell Physiology
Hutagalung, A. H., & Novick, P. J. (2011) · Physiological Reviews · doi:10.1152/physrev.00059.2009 · Cited by 1,460
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451
Ratajczak, J., Wysoczynski, M., Hayek, F., Janowska-Wieczorek, A., & Ratajczak, M. Z. (2006) · Leukemia · doi:10.1038/sj.leu.2404296 · Cited by 1,340
Exosomes/microvesicles as a mechanism of cell-to-cell communication
Camussi, G., Deregibus, M. C., Bruno, S., Cantaluppi, V., & Biancone, L. (2010) · Kidney International · doi:10.1038/ki.2010.278 · Cited by 1,178
Exosomes: secreted vesicles and intercellular communications
Théry, C. (2011) · F1000 Biology Reports · doi:10.3410/b3-15 · Cited by 989
The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
Bonci, D., Coppola, V., Musumeci, M., Addario, A., Giuffrida, R., Memeo, L., D'Urso, L., Pagliuca, A., Biffoni, M., Labbaye, C., et al. (2008) · Nature Medicine · doi:10.1038/nm.1880 · Cited by 989
Tea polyphenols: prevention of cancer and optimizing health
Mukhtar, H., & Ahmad, N. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1698s · Cited by 904
“Re-educating” tumor-associated macrophages by targeting NF-κB
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080108 · Cited by 792
MicroRNA function: Multiple mechanisms for a tiny RNA?: FIGURE 1.
PILLAI, R. S. (2005) · RNA · doi:10.1261/rna.2248605 · Cited by 681
Diet, nutrition and the prevention of cancer
Key, T. J., Schatzkin, A., Willett, W. C., Allen, N. E., Spencer, E. A., & Travis, R. C. (2004) · Public Health Nutrition · doi:10.1079/phn2003588 · Cited by 648
Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells
Pigati, L., Yaddanapudi, S. C. S., Iyengar, R., Kim, D.-J., Hearn, S. A., Danforth, D., Hastings, M. L., & Duelli, D. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013515 · Cited by 582
Bobrie, A., Colombo, M., Krumeich, S., Raposo, G., & Théry, C. (2012) · Journal of Extracellular Vesicles · doi:10.3402/jev.v1i0.18397 · Cited by 579
Safaei, R., Larson, B. J., Cheng, T. C., Gibson, M. A., Otani, S., Naerdemann, W., & Howell, S. B. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0102 · Cited by 564
Majka, M., Janowska-Wieczorek, A., Ratajczak, J., Ehrenman, K., Pietrzkowski, Z., Kowalska, M. A., Gewirtz, A. M., Emerson, S. G., & Ratajczak, M. Z. (2001) · Blood · doi:10.1182/blood.v97.10.3075 · Cited by 508
Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations
Lambert, J. D., Hong, J., Yang, G.-Y., Liao, J., & Yang, C. S. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.284s · Cited by 499
Tumour-released exosomes and their implications in cancer immunity
Iero, M., Valenti, R., Huber, V, Filipazzi, P., Parmiani, G., Fais, S., & Rivoltini, L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402237 · Cited by 485
miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes
Liu, Q., Fu, H., Sun, F., Zhang, H., Tie, Y., Zhu, J., Xing, R., Sun, Z., & Zheng, X. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn522 · Cited by 477
Saccani, A., Schioppa, T., Porta, C., Biswas, S. K., Nebuloni, M., Vago, L., Bottazzi, B., Colombo, M. P., Mantovani, A., & Sica, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1867 · Cited by 455
Exosome/microvesicle-mediated epigenetic reprogramming of cells.
Camussi, G., Deregibus, M. C., Bruno, S., Grange, C., Fonsato, V., & Tetta, C. (2011) · American Journal of Cancer Research · Cited by 431
Takeshita, F., Patrawala, L., Osaki, M., Takahashi, R.-U., Yamamoto, Y., Kosaka, N., Kawamata, M., Kelnar, K., Bader, A. G., Brown, D., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2009.207 · Cited by 420
Macrophages define the invasive microenvironment in breast cancer
Pollard, J. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107762 · Cited by 417
Kim, H. K., Song, K. S., Park, Y. S., Kang, Y. H., Lee, Y. J., Lee, K. R., Kim, H. K., Ryu, K. W., Bae, J. M., & Kim, S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00596-8 · Cited by 401
Tumor-Associated Macrophages in Breast Cancer
Leek, R. D., & Harris, A. L. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1020304003704 · Cited by 351
Li, T., Morgan, M. J., Choksi, S., Zhang, Y., Kim, Y.-S., & Liu, Z.-G. (2010) · Nature Immunology · doi:10.1038/ni.1918 · Cited by 339
Rozmyslowicz, T., Majka, M., Kijowski, J., Murphy, S. L., Conover, D. O., Poncz, M., Ratajczak, J., Gaulton, G. N., & Ratajczak, M. Z. (2003) · AIDS · doi:10.1097/00002030-200301030-00006 · Cited by 337
Lu, Y.-P., Lou, Y.-R., Xie, J.-G., Peng, Q.-Y., Liao, J., Yang, C. S., Huang, M.-T., & Conney, A. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182429899 · Cited by 316
Thangapazham, R. L., Singh, A. K., Sharma, A., Warren, J., Gaddipati, J. P., & Maheshwari, R. K. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.01.027 · Cited by 308
Adhami, V. M., Siddiqui, I. A., Ahmad, N., Gupta, S., & Mukhtar, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2840 · Cited by 296
Regulation of macrophage function in tumors: the multifaceted role of NF-κB
Hagemann, T., Biswas, S. K., Lawrence, T., Sica, A., & Lewis, C. E. (2009) · Blood · doi:10.1182/blood-2008-12-172825 · Cited by 248
Cytonemes and tunneling nanotubules in cell–cell communication and viral pathogenesis
Sherer, N. M., & Mothes, W. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.07.003 · Cited by 241
Tumor Vesicle—Associated CD147 Modulates the Angiogenic Capability of Endothelial Cells
Millimaggi, D., Mari, M., D'Ascenzo, S., Carosa, E., Jannini, E. A., Zucker, S., Carta, G., Pavan, A., & Dolo, V. (2007) · Neoplasia · doi:10.1593/neo.07133 · Cited by 237
Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
Chew, V., Toh, H. C., & Abastado, J.-P. (2012) · Journal of Oncology · doi:10.1155/2012/608406 · Cited by 218
Ofir, M., Hacohen, D., & Ginsberg, D. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0344 · Cited by 183
Inhibitory effect of green tea on the growth of established skin papillomas in mice.
Wang, Z. Y., Huang, M., Ho, C., Chang, R. L., Ma, W., Ferraro, T., Reuhl, K. R., Yang, C. S., & Conney, A. H. (1992) · PubMed · Cited by 171
Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer
Stuart, E. C., Scandlyn, M. J., & Rosengren, R. J. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.07.036 · Cited by 170
Oncogenic Wip1 Phosphatase Is Inhibited by miR-16 in the DNA Damage Signaling Pathway
Zhang, X., Wan, G., Mlotshwa, S., Vance, V. B., Berger, F. G., Chen, H., & Lu, X. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0697 · Cited by 160
Inflammation and cancer: Breast cancer as a prototype
Mantovani, A., Marchesi, F., Porta, C., Sica, A., & Allavena, P. (2007) · The Breast · doi:10.1016/j.breast.2007.07.013 · Cited by 159
Lü, G., Liao, J., Yang, G., Reuhl, K. R., Hao, X., & Yang, C. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1497 · Cited by 155
The epidemiology of breast cancer
Kelsey, J. L., & Gammon, M. D. (1991) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.41.3.146 · Cited by 143
Possible mechanisms of the cancer‐preventive activities of green tea
Yang, C. S., Sang, S., Lambert, J. D., Hou, Z., Ju, J., & Lü, G. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500105 · Cited by 100
Şahin, K., Tuzcu, M., Başak, N., Çağlayan, B., Kılıç, Ü., Sahin, F., & Kucuk, O. (2012) · Journal of Oncology · doi:10.1155/2012/461562 · Cited by 96
Tumor-Associated Macrophage: Its Role in Cancer Invasion and Metastasis
Shih, J.-Y., Yuan, A., Chen, J. J., & Yang, P. (2006) · doi:10.29685/jcm.200606.0001 · Cited by 79
Zhang, G., Miura, Y., & Yagasaki, K. (1999) · Cytotechnology · doi:10.1023/a:1008076306672 · Cited by 45
Metabolic syndrome and breast cancer: an overview.
Gezgen, G., Roach, E. C., Kızılarslanoğlu, M. C., Petekkaya, İ., & Altundağ, K. (2012) · PubMed · Cited by 18
Cited by
Broad targeting of resistance to apoptosis in cancer
Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H.-Y., Lin, L.-T., Siegelin, M. D., Fimognari, C., Kumar, N. B., Dou, Q. P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.001 · Cited by 864
Pascucci, L., Coccè, V., Bonomi, A., Ami, D., Ceccarelli, P., Ciusani, E., Viganò, L., Locatelli, A., Sisto, F., Doglia, S. M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.042 · Cited by 846
Essandoh, K., Li, Y., Huo, J., & Fan, G.-C. (2016) · Shock · doi:10.1097/shk.0000000000000604 · Cited by 606
Exosomes and their roles in immune regulation and cancer
Greening, D. W., Gopal, S. K., Xu, R., Simpson, R. J., & Chen, W. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.02.009 · Cited by 597
Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
Luo, H., Vong, C. T., Chen, H., Gao, Y., Lyu, P., Qiu, L., Zhao, M., Liu, Q., Cheng, Z., Zou, J., et al. (2019) · Chinese Medicine · doi:10.1186/s13020-019-0270-9 · Cited by 563
Metadata
- Authors
- Jang, J.-Y., Lee, J.-K., Jeon, Y.-K., & Kim, C.-W.
- Venue
- BMC Cancer
- Published
- 2013-09-17
- Volume
- 13
- Issue
- 1
- Pages
- 421-421
- ISSN
- 1471-2407 (ISSN-L)
- OpenAlex
- W2132099454
- Cited by
- 270
- References
- 49
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.